| 571 |
Centers for Disease Control and Prevention |
Html |
en |
Food Safety Tips for your Holiday Turkey | CDC Features |
Food handling errors and inadequate cooking are the most common problems that lead to poultry-associated foodborne disease outbreaks in the United States . Follow these four food safety tips to help you safely prepare your next holiday turkey meal. |
| stuffing | 0.912411 |
| inadequate cooking | 0.623909 |
| foods | 0.391259 |
| thigh | 0.359054 |
| chill | 0.351151 |
| food thermometer | 0.948187 |
| casserole dish | 0.57426 |
| common problems | 0.578695 |
| danger | 0.34853 |
| cold water | 0.584839 |
| thawing turkey | 0.599484 |
| Clostridium perfringens | 0.578588 |
| Cook stuffing | 0.751191 |
| preparation | 0.34473 |
| inches | 0.346857 |
| zone | 0.347156 |
| safety – cook | 0.544611 |
| vomiting | 0.352931 |
| foodborne disease outbreaks | 0.835218 |
| roasting pan | 0.53825 |
| sink | 0.357445 |
| minimum cooking temperatures | 0.750371 |
| cavity | 0.350124 |
| common bacterial cause | 0.743233 |
| stuffing’s center | 0.739625 |
|
| oven temperature | 0.611173 |
| frozen turkey | 0.58039 |
| turkey | 0.948743 |
| refrigerator | 0.359012 |
| thickest portions | 0.559256 |
| Symptoms | 0.345747 |
| Thaw turkeys | 0.620221 |
| room temperature | 0.837049 |
| abdominal cramps | 0.571255 |
| food safety tips | 0.827025 |
| raw poultry | 0.565353 |
| United States.1 Follow | 0.819078 |
| leftovers | 0.358594 |
| safe internal temperature | 0.783834 |
| microwave | 0.347898 |
| food poisoning | 0.99889 |
| holiday turkey | 0.607938 |
| Food handling errors | 0.836131 |
| counter | 0.349844 |
| Cooking times | 0.549995 |
| meal | 0.350252 |
| completely thawed turkey | 0.74088 |
| safe temperature | 0.614572 |
| family | 0.346185 |
|
CLICK HERE |
| 673 |
Centers for Disease Control and Prevention |
Html |
en |
Smoking & Tobacco Use - MMWRs |
MMWRs Feed. |
| MMWR readership | 0.558248 |
| CDC | 0.217817 |
| Mortality Weekly Report | 0.939813 |
| informational purposes | 0.511842 |
| fact sheets | 0.469965 |
| recent information | 0.461961 |
| Disclaimer | 0.239178 |
|
| Morbidity | 0.256661 |
| weekly reports | 0.521702 |
| epidemiologists | 0.263023 |
| public health departments | 0.881854 |
| regular basis | 0.480994 |
| scientific public health | 0.84792 |
| public health professionals | 0.781548 |
|
CLICK HERE |
| 5434 |
Centers for Disease Control and Prevention |
Html |
en |
CDC Identifies Top Global Public Health Achievements in First Decade of 21st Century - Press Release: June 23, 2011 |
No Progress in Salmonella During Past 15 Years |
| Global Health Threats | 0.587283 |
| new HIV infections | 0.535484 |
| Mortality Weekly Report | 0.587834 |
| safe water | 0.798279 |
| Global Disease Detection | 0.566568 |
| diphtheria-tetanus-pertussis vaccines | 0.56618 |
| indoor residual spraying | 0.540891 |
| public health achievements | 0.722476 |
| Global Tobacco Surveillance | 0.578994 |
| Improving Global Road | 0.553932 |
| public health surveillance | 0.565368 |
| safe water technology | 0.583901 |
| global deaths | 0.56952 |
| Enforce marketing bans | 0.534905 |
| deaths | 0.638215 |
| safe water practices | 0.553638 |
| drinking water sources | 0.552264 |
| World Health Organization | 0.679429 |
| Guinea worm | 0.615453 |
| mass drug administration | 0.644263 |
| child mortality rate | 0.566345 |
| AIDS-related deaths | 0.536089 |
| Onchocerciasis Elimination Program | 0.541002 |
| TB control | 0.600579 |
| global public health | 0.975541 |
|
| Neglected Tropical Diseases | 0.536285 |
| International Health Regulations | 0.565478 |
| tobacco-related health information | 0.560077 |
| Directly Observed Therapy | 0.540871 |
| insecticide-treated bednets | 0.583369 |
| traffic-related mortality rates | 0.553394 |
| substantially fewer deaths | 0.632578 |
| annual traffic-related deaths | 0.583803 |
| safe water programs | 0.555421 |
| 21st century | 0.565555 |
| public health advances | 0.604316 |
| Dr. Thomas Frieden. | 0.552026 |
| drinking water | 0.553851 |
| standardized drug regimens | 0.540594 |
| international influenza response | 0.536804 |
| TB cases | 0.557542 |
| oral rehydration therapy | 0.55281 |
| Tobacco Control | 0.551565 |
| Public Health Information | 0.568967 |
| Global Road Safety | 0.642387 |
| major infectious causes | 0.558124 |
| average life expectancy | 0.559843 |
| WHO-developed MPOWER package | 0.53515 |
| Guinea worm disease | 0.568135 |
|
CLICK HERE |
| 6483 |
Centers for Disease Control and Prevention |
Html |
en |
Objective measurement of physical activity and sedentary behavior among US adults aged 60 years or older |
Estimates of objectively measured physical activity among older adults differ depending on the cut points used to define intensity. Our objective was to assess 1) moderate to vigorous physical activity (MVPA), exploring differences in prevalence depending on the cut point used, and 2) sedentary behavior, among US adults aged 60 years or older. |
| counts | 0.354117 |
| moderate-intensity physical activity | 0.287279 |
| cardiorespiratory fitness | 0.295837 |
| accelerometer cut points | 0.39718 |
| absolute-intensity physical activity | 0.281067 |
| Nutrition Examination Survey | 0.462848 |
| ActiGraph accelerometer | 0.323709 |
| vigorous physical activity | 0.291578 |
| cut point | 0.773675 |
| consistent MVPA | 0.312604 |
| racial/ethnic groups | 0.310799 |
| National Health | 0.338944 |
| older age groups | 0.290826 |
| available accelerometer data | 0.311345 |
| vigorous-intensity physical activity | 0.286766 |
| cut point decisions | 0.324856 |
| David M. Buchner | 0.303008 |
| group-level cut points | 0.311673 |
| optimal cut points | 0.312811 |
| relative-intensity physical activity | 0.317228 |
| counts/min | 0.278427 |
| recent accelerometer data | 0.302182 |
| NHANES physical activity | 0.294874 |
| moderate-intensity cut points | 0.312721 |
| Kelly R. Evenson | 0.300883 |
|
| age group | 0.368844 |
| accelerometer cut point | 0.387704 |
| accelerometer data | 0.386447 |
| Kimberly B. Morland | 0.299554 |
| MVPA estimates | 0.333473 |
| accelerometer | 0.402688 |
| non-Hispanic blacks | 0.294162 |
| physical activity recommendations | 0.31655 |
| small sample size | 0.282361 |
| non-Hispanic whites | 0.327175 |
| sedentary behavior | 0.507224 |
| participants | 0.408379 |
| non-Hispanic white adults | 0.2871 |
| vigorous-intensity activity | 0.278989 |
| correct cut point | 0.313955 |
| cut points | 0.656112 |
| highest cut point | 0.317715 |
| physical activity | 0.960367 |
| national physical activity | 0.283804 |
| older adults | 0.526237 |
| incomplete accelerometer data | 0.296288 |
| NHANES | 0.328725 |
| confidence interval | 0.279972 |
| MVPA | 0.607551 |
|
CLICK HERE |
| 6817 |
Centers for Disease Control and Prevention |
Html |
en |
Genital Herpes - CDC Fact Sheet |
Genital Herpes Fact Sheet from CDC. What is Herpes? How common is Herpes? How do people get Herpes? And more... |
| genital secretions | 0.404889 |
| prenatal care visits | 0.351676 |
| health care provider | 0.39406 |
| Association (ASHA) | 0.349112 |
| herpes symptoms | 0.535854 |
| American Sexual Health | 0.348647 |
| CDC National Prevention | 0.349216 |
| herpes virus | 0.539545 |
| herpes antibodies | 0.488177 |
| sex partner | 0.467312 |
| sexually active person | 0.356957 |
| oral sex | 0.446235 |
| genital herpes diagnosis | 0.563813 |
| genital herpes | 0.93459 |
| cold sores | 0.362277 |
| painful genital sores | 0.439334 |
| sexually transmitted disease | 0.359619 |
| suppressed immune systems | 0.349532 |
| oral herpes | 0.643531 |
| Research Triangle Park | 0.347801 |
| STD test results | 0.366693 |
| painful sores | 0.354895 |
| herpes sores | 0.565863 |
| visible herpes | 0.501347 |
|
| potentially deadly infection | 0.365794 |
| sex partners | 0.358953 |
| HIV-uninfected sex partner | 0.366193 |
| future sexual relationships | 0.347333 |
| P. O. Box | 0.348798 |
| smelly genital discharge | 0.418539 |
| mild symptoms | 0.352403 |
| herpes simplex virus | 0.577408 |
| genital area | 0.403212 |
| STD Clinics | 0.33654 |
| neonatal herpes | 0.497383 |
| simplex virus type | 0.403422 |
| oral herpes infection | 0.580156 |
| mutually monogamous relationship | 0.354678 |
| genital herpes infection | 0.693975 |
| visible sores | 0.34849 |
| flu-like symptoms | 0.336024 |
| partner’s mouth | 0.340667 |
| STD symptoms | 0.345818 |
| people | 0.356072 |
| Daily suppressive therapy | 0.348946 |
| healthcare provider | 0.385535 |
| oral area | 0.340643 |
| risk | 0.340531 |
|
CLICK HERE |
| 9581 |
Centers for Disease Control and Prevention |
Html |
en |
CDC Newsroom Image Library Buildings and Facilities | CDC Media Relations |
Free public health images, medical images, high-resolution, public domain images. |
| PHIL ID number | 0.258483 |
| James Gathany | 0.38262 |
| organization′s Roybal Campus | 0.366596 |
| content provider | 0.284851 |
| Tom Harkin Global | 0.24594 |
|
| Disease Control | 0.381703 |
| CDC′s Roybal campus | 0.942536 |
| Emergency Operations Center | 0.671335 |
| Photo Credit | 0.38317 |
| Arlen Specter Headquarters | 0.809351 |
|
CLICK HERE |
| 13828 |
Centers for Disease Control and Prevention |
Html |
en |
National Epilepsy Awareness Month - November 2015 |
Epilepsy is a brain disorder characterized by recurrent seizures; an estimated 2.9 million persons in the United States have active epilepsy (1). A seizure is a brief change in normal brain activity that changes awareness, behavior, or body movement. |
| low blood sugar | 0.914468 |
| endorsement | 0.685821 |
| brain disorder | 0.796948 |
| Human Services | 0.927021 |
| U.S. Department | 0.919952 |
| MMWR HTML versions | 0.898577 |
| emergencies | 0.63302 |
| children | 0.63088 |
| electronic PDF version | 0.889912 |
| recurrent seizures | 0.945308 |
| seizures | 0.948216 |
| injury | 0.658676 |
| changes awareness | 0.797275 |
| issue | 0.659022 |
| Additional information | 0.772825 |
| Contact GPO | 0.795531 |
| nearby objects | 0.773763 |
| normal brain activity | 0.960248 |
| commercial sources | 0.769443 |
| different types | 0.804881 |
| current prices | 0.762584 |
| persons | 0.662381 |
| original paper copy | 0.897555 |
| person | 0.875382 |
|
| difficulty breathing | 0.771104 |
| seizure | 0.983546 |
| United States | 0.97872 |
| U.S. Government Printing | 0.905454 |
| original MMWR paper | 0.893138 |
| public need | 0.782968 |
| Superintendent | 0.632396 |
| active epilepsy | 0.816364 |
| MMWR readers | 0.771242 |
| character translation | 0.761574 |
| convulsive seizure | 0.933253 |
| brief change | 0.800149 |
| floor | 0.654961 |
| behavior | 0.632987 |
| format errors | 0.761645 |
| airway | 0.63926 |
| typeset documents | 0.768367 |
| trade names | 0.769557 |
| health | 0.687702 |
| official text | 0.759705 |
| non-CDC sites | 0.765629 |
| body movement | 0.799602 |
| report | 0.630926 |
| electronic conversions | 0.757423 |
|
CLICK HERE |
| 13924 |
Centers for Disease Control and Prevention |
Html |
en |
Notes from the Field: Carbapenem-resistantEnterobacteriaceae Producing OXA-48-like Carbapenemases - UnitedStates, 2010-2015 |
The Morbidity and Mortality Weekly Report (MMWR) Series is prepared by the Centers for Disease Control and Prevention (CDC). Often called 'the Voice of CDC,' the MMWR series is the agency's primary vehicle for scientific publication of timely, reliable, authoritative, accurate, objective, and useful public health information and recommendations. MMWR readership predominately consists of physicians, nurses, public health practitioners, epidemiologists and other scientists, researchers, educators, and laboratorians. |
| U.S. reports | 0.22594 |
| rapid global dissemination | 0.328095 |
| carbapenemase-producing CRE | 0.619213 |
| additional published reports | 0.329127 |
| OXA-48 carbapenemase | 0.236227 |
| CDC Health Advisory | 0.335635 |
| U.S. clinical laboratories | 0.301224 |
| Zoonotic Infectious Diseases | 0.305979 |
| Maroya Walters | 0.237775 |
| different susceptibility profiles | 0.307609 |
| K. pneumoniae | 0.37804 |
| carbapenem antibiotics | 0.232509 |
| OXA-48-like carbapenemase genes | 0.347322 |
| patients | 0.547463 |
| OXA-48-like carbapenemases | 0.777871 |
| Brandi Limbago | 0.241756 |
| carbapenemase enzymes | 0.236561 |
| Kamile Rasheed | 0.251654 |
| Klebsiella pneumoniae carbapenemase | 0.403571 |
| Meghan Lyman | 0.250921 |
| CRE | 0.806063 |
| health care settings | 0.308734 |
| high transfer efficiency | 0.302421 |
| 1Epidemic Intelligence Service | 0.30877 |
|
| Klebsiella ozaenae isolate | 0.354316 |
| health care–associated infections | 0.342189 |
| United States | 0.913286 |
| CDC CRE surveillance | 0.596093 |
| Meghan M. Lyman | 0.316523 |
| non-K. pneumoniae carbapenemases | 0.351619 |
| Healthcare Quality Promotion | 0.308541 |
| New Delhi metallo-β-lactamase | 0.549854 |
| plasmid-mediated resistance | 0.244786 |
| OXA-48-producing CRE | 0.476667 |
| public health concern | 0.340617 |
| frequently reported destination | 0.321945 |
| different clusters | 0.225961 |
| Alexander Kallen | 0.242078 |
| high mortality rates | 0.336818 |
| OXA-48-like genes | 0.232859 |
| OXA-48-like variants | 0.247702 |
| CRE resistance mechanisms | 0.585753 |
| enhanced environmental cleaning | 0.329196 |
| CRE screening | 0.481109 |
| Newly described resistance | 0.344355 |
| David Lonsway | 0.239262 |
| U.S. K. pneumoniae | 0.370653 |
| isolates | 0.313706 |
|
CLICK HERE |
| 14340 |
Centers for Disease Control and Prevention |
Image |
null |
Tracking down the salt in food with Professor Saul T. |
null |
|
|
CLICK HERE |
| 16506 |
Centers for Disease Control and Prevention |
Html |
en |
Guideline Resources: Mobile App |
null |
| Apple Store | 0.408355 |
| Morphine Milligram Equivalent | 0.543535 |
| chronic pain | 0.542776 |
| new Opioid Guideline | 0.807861 |
| renal insufficiency | 0.416518 |
| palm | 0.31956 |
| clinical practice | 0.421488 |
| approximations | 0.326448 |
| palliative care | 0.408634 |
| tools | 0.31961 |
| genetic factors | 0.404624 |
| different opioids | 0.534435 |
| iOS devices | 0.417932 |
| patient weight | 0.401885 |
| free download | 0.408926 |
| Opioid Guideline App | 0.99731 |
| Prescribing Opioids | 0.58693 |
| Google Play | 0.406757 |
| incomplete cross-tolerance | 0.405731 |
| fentanyl | 0.329067 |
| pharmacokinetics | 0.328391 |
| *MME Calculator Disclaimer | 0.52137 |
| CDC’s Guideline | 0.572193 |
|
| hand | 0.319535 |
| calculator* | 0.317938 |
| Android devices | 0.415293 |
| patients | 0.328684 |
| confidence | 0.319565 |
| opioid rotation | 0.538887 |
| clinical judgement | 0.414046 |
| resources | 0.319585 |
| opioid dosing | 0.56739 |
| methadone conversions | 0.40736 |
| active cancer treatment | 0.493992 |
| opioid use disorder | 0.540045 |
| application | 0.333498 |
| guidance | 0.338952 |
| interactive motivational interviewing | 0.510216 |
| effective communications skills | 0.504336 |
| CDC Opioid Guideline | 0.778169 |
| key recommendations | 0.415024 |
| entire guideline | 0.532951 |
| Equianalgesic dose ratios | 0.500838 |
| medication-assisted treatment | 0.402412 |
| providers | 0.336382 |
|
CLICK HERE |